Beth Israel Deaconess Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Beth Israel Deaconess Medical Center sits in the top decile of US sponsors by registered trial count (#75 of 15,742 sponsors by registered trial count).
Beth Israel Deaconess Medical Center: 488 sponsored US clinical trials, 66 recruiting.
Beth Israel Deaconess Medical Center sponsors 488 registered US clinical trials on ClinicalTrials.gov, 66 of them currently recruiting, and 321 completed. 45 of these trials are in Phase 3-4 (later-stage) and 144 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 8 trials.
Top-decile sponsor footprint
Beth Israel Deaconess Medical Center ranks in the top decile of sponsors by registered trial count (#75 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
321 of 380 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
488 total, page 9 of 10
tDCS and Physical Therapy in Stroke
NCT00542256
Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation
NCT00794911
A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation
NCT00785265
Migraine--Investigational Treatment of Migraine With Noninvasive Brain Stimulation. (tDCS- Migraine)
NCT00521196
Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials
NCT00620698
The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
NCT00456885
Transcranial Direct Current Stimulation (TDCS) for Facilitating Swallowing Improvement After an Acute Unilateral Hemispheric Stroke
NCT01132066
Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer
NCT00458237
Radiosurgery for Glioblastoma Multiforme
NCT00456612
Quality of Life Therapy for Adults With ESRD Awaiting Renal Transplantation
NCT00428012
Control of Leukocyte Function
NCT03027232
Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period
NCT00586196
Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
NCT00421252
Impaired Wound Healing in Diabetic Foot Ulceration
NCT00739323
The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma
NCT00554515
Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome
NCT00362440
Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke Recovery
NCT00792428
Amino Acids, Serotonin, and Body Weight Regulation
NCT00343928
TMS for the Treatment of Pancreatic Cancer Pain
NCT00324428
Effects of Atorvastatin on Myonecrosis
NCT00344019
Short Course of Radiation for Gliomas in Elderly Patients
NCT00386919
Laser Light Cues for Gait Freezing in Parkinson's Disease
NCT00320242
CyberKnife for Unresectable Renal Tumors
NCT00807339
Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery
NCT00328094
A Study to Look at Antiepileptic Drug Levels While on Lamictal or Depakote With or Without an Oral Contraceptive
NCT00296413
Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection
NCT00300495
Linkage Analysis in Interstitial Cystitis
NCT00675298
Fat Tolerance From Lipid Emulsion Infusion Packaged in Glass or Plastic
NCT00278928
Evaluation of DHA for the Treatment of PSC
NCT00325013
Tai Chi Mind-Body Therapy for Chronic Heart Failure
NCT00110227
Restoring Sleep Homeostasis to Lower Blood Pressure
NCT01008176
Molecular Processes of the Relaxation Response in Older Adults
NCT00179569
Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma
NCT00458653
Caffeine in the Prevention of Post-operative Nausea and Vomiting
NCT00130026
Study of Fine Art Photographs and Visualization Tapes to Improve Surgical Recovery in Breast Cancer
NCT00179634
Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia
NCT00434980
Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer
NCT00673127
Intraoperative Pathway in DIEP Flap Breast Reconstruction
NCT00543764
Patient Computer Dialog in Primary Care
NCT00386776
Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS
NCT00179582
Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer
NCT00253708
TMS Treatment for Pain in Chronic Pancreatitis
NCT00250484
Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
NCT00458536
The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma
NCT00459069
Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)
NCT01132053
Mechanical Ventilation, Directed by Esophageal Pressure Measurements, in Patients With Acute Lung Injury
NCT00127491
Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
NCT00585078
Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
NCT00110149
Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects
NCT00136214
NPDT Evaluation in Children With CFTR and (PSC)
NCT00179439
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 53 |
| Phase 2 | 91 |
| Phase 3 | 13 |
| Phase 4 | 32 |
Therapeutic Areas
What is open in the Beth Israel Deaconess Medical Center pipeline
66 recruiting of 488 indexed (14% open); 321 completed (66%).
Phase mix: 45 late (III/IV) vs 144 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Beth Israel Deaconess Medical Center: open-pipeline peers nationwide
Peers matched on 488 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Beth Israel Deaconess Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 488 trials (± recruiting share)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 490 trials · 10% recruiting
- Fred Hutchinson Cancer Center · 483 trials · 12% recruiting
- National Heart, Lung, and Blood Institute (NHLBI) · 501 trials · 12% recruiting
- H. Lee Moffitt Cancer Center and Research Institute · 502 trials · 16% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Wayne State University · 13% recruiting · 163 trials
- University of Michigan · 13% recruiting · 1,327 trials
- Albany Medical College · 13% recruiting · 52 trials
Related
What to do with this Beth Israel Deaconess Medical Center page
488 registered trials is a research-attention snapshot, not an endorsement of Beth Israel Deaconess Medical Center or any single study.
- 66 of Beth Israel Deaconess Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Beth Israel Deaconess Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Beth Israel Deaconess Medical Center pipeline card: 488 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.